Status: Planned
Planned sterile IV fluid
0.9% Sodium Chloride Injection
A planned category within the proposed initial sterile IV-fluid portfolio.
Our Products
A focused portfolio built around essential hospital medicines.
Biogenix’s initial product direction is centred on sterile intravenous fluids, followed over time by carefully selected generic injectable medicines. All products remain subject to technical development, manufacturing readiness and applicable regulatory approval.
Portfolio Introduction
A deliberate development path, beginning with sterile fluid therapy categories.
The proposed initial portfolio brings together five large-volume parenteral categories. Selection reflects the company’s intended focus on essential hospital medicines while product development, presentation and manufacturing decisions continue.
No product shown on this page is presented as registered, approved, commercially manufactured or available for purchase.
Planned IV-Fluid Portfolio
Five proposed categories for the initial platform.
The collection below is sourced from the website’s controlled product records. It provides development context only and contains no prescribing information.
Proposed initial IV-fluid portfolioDevelopment-stage artwork
Artwork status
Concept packaging, not approved product information.
The visual presents an initial portfolio direction only. Product selection, strengths, formulations, pack sizes, label statements and final artwork remain subject to technical, commercial and regulatory review. The products are not presented as registered, manufactured or available for purchase.
Status: Planned
Planned sterile IV fluid
Ringer's Lactate Injection
A planned category within the proposed initial sterile IV-fluid portfolio.
Status: Planned
Planned sterile IV fluid
5% Dextrose Injection
A planned category within the proposed initial sterile IV-fluid portfolio.
Status: Planned
Planned sterile IV fluid
10% Dextrose Injection
A planned category within the proposed initial sterile IV-fluid portfolio.
Status: Planned
Planned sterile IV fluid
Hypertonic Saline
A planned category within the proposed initial sterile IV-fluid portfolio.
Longer-Term Visual Exploration
An early concept for selected generic injectable medicines.
This artwork explores possible longer-term portfolio directions. It is not a confirmed product pipeline and does not establish registration, approved indications, manufacturing status or commercial availability.
Important:
Names, strengths, presentations, routes and clinical statements visible in the concept remain subject to product-by-product assessment and formal review. They must not be used as prescribing or treatment information.
Possible longer-term injectable conceptsDevelopment-stage artwork
Future Portfolio Direction
Longer-term development guided by need, capability and evidence.
Potential areas will require individual clinical, technical, market and regulatory assessment. The list does not represent a committed product pipeline.
- 01Hospital anti-infective injectables
- 02Analgesic and antipyretic injectables
- 03Emergency and critical-care medicines
- 04Anaesthetic and peri-operative medicines
- 05Gastrointestinal medicines
- 06Cardiovascular medicines
- 07Other essential injectable medicines selected through clinical and market assessment
Understanding Product Status
Controlled terms for clear product communication.
These definitions explain statuses the website may use over time. A status will be applied to a product only when it accurately reflects confirmed information.
- Planned
- Identified as part of the intended portfolio; not submitted or approved.
- Under Development
- Technical development activity is underway; regulatory approval has not been granted.
- Submitted
- A regulatory submission has been made and remains subject to review.
- Approved
- Applicable regulatory authorization has been granted for the stated product.
- Unavailable
- The product is not currently available for supply.
Healthcare Professional Resources
Approved information will be published when it becomes available.
This area is intended for approved product information, package inserts, medical-information enquiries, product availability information and safety notices. No approved resources are currently published.
Manufacturing Direction
Explore the planned platform behind the portfolio.
Learn how Biogenix is approaching sterile manufacturing technology, process control and supporting capabilities.